SCO-267
CAS: 1656261-09-4
Ref. 3D-BS179509
1mg | 225,00 € | ||
2mg | 352,00 € | ||
5mg | 587,00 € | ||
10mg | 969,00 € | ||
25mg | 1.824,00 € |
Informação sobre produto
SCO-267 is a novel small molecule that has been shown to increase insulin sensitivity in mice by activating the protein kinase Akt3. SCO-267 is orally active and penetrates the blood brain barrier to exert its effects. It has been shown to improve glucose tolerance and insulin sensitivity in wild-type mice, as well as reduce plasma ALT levels in neonatal mice. SCO-267 also activates Akt3 in min6 cells, which are a pancreatic beta cell line. This activation leads to increased fatty acid oxidation and reduced triglyceride accumulation. In knockout mice, SCO-267 was shown to protect against fatty liver disease induced by chronic exposure to ethanol or high fat diet.
Propriedades químicas
Consulta técnica sobre: 3D-BS179509 SCO-267
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.